BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28484923)

  • 1. Circulating levels of obesity-related markers and risk of renal cell carcinoma in the PLCO cancer screening trial.
    Liao LM; Hofmann JN; Cho E; Pollak MN; Chow WH; Purdue MP
    Cancer Causes Control; 2017 Jul; 28(7):801-807. PubMed ID: 28484923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High circulating insulin-like growth factor-1 reduces the risk of renal cell carcinoma: a Mendelian randomization study.
    Chen M; Tsai CW; Chang WS; Xiong GY; Xu Y; Bau DT; Gu J
    Carcinogenesis; 2021 Jun; 42(6):826-830. PubMed ID: 33852723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediagnostic circulating adipokine concentrations and risk of renal cell carcinoma in male smokers.
    Liao LM; Weinstein SJ; Pollak M; Li Z; Virtamo J; Albanes D; Chow WH; Purdue MP
    Carcinogenesis; 2013 Jan; 34(1):109-12. PubMed ID: 23042303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Douglas JB; Silverman DT; Pollak MN; Tao Y; Soliman AS; Stolzenberg-Solomon RZ
    Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2298-306. PubMed ID: 20699371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.
    Kaaks R; Toniolo P; Akhmedkhanov A; Lukanova A; Biessy C; Dechaud H; Rinaldi S; Zeleniuch-Jacquotte A; Shore RE; Riboli E
    J Natl Cancer Inst; 2000 Oct; 92(19):1592-600. PubMed ID: 11018095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender difference in the association of insulin and the insulin-like growth factor axis with colorectal neoplasia.
    Yamaji T; Iwasaki M; Sasazuki S; Tsugane S
    Int J Obes (Lond); 2012 Mar; 36(3):440-7. PubMed ID: 21673650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405.
    Guercio BJ; Zhang S; Ou FS; Venook AP; Niedzwiecki D; Lenz HJ; Innocenti F; Pollak MN; Nixon AB; Mullen BC; O'Neil BH; Shaw JE; Polite BN; Benson AB; Atkins JN; Goldberg RM; Brown JC; O'Reilly EM; Mayer RJ; Blanke CD; Fuchs CS; Meyerhardt JA
    JNCI Cancer Spectr; 2021 Feb; 5(1):. PubMed ID: 33426464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity-related hormones and endometrial cancer among postmenopausal women: a nested case-control study within the B~FIT cohort.
    Dallal CM; Brinton LA; Bauer DC; Buist DS; Cauley JA; Hue TF; Lacroix A; Tice JA; Chia VM; Falk R; Pfeiffer R; Pollak M; Veenstra TD; Xu X; Lacey JV;
    Endocr Relat Cancer; 2013 Feb; 20(1):151-60. PubMed ID: 23222000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum leptin and adiponectin levels and risk of renal cell carcinoma.
    Liao LM; Schwartz K; Pollak M; Graubard BI; Li Z; Ruterbusch J; Rothman N; Davis F; Wacholder S; Colt J; Chow WH; Purdue MP
    Obesity (Silver Spring); 2013 Jul; 21(7):1478-85. PubMed ID: 23666639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer risk in relation to insulin-like growth factor (IGF)-I and IGF-binding protein-3: A nested case-control study in large scale cohort study in Japan.
    Mikami K; Ozasa K; Nakao M; Miki T; Hayashi K; Watanabe Y; Mori M; Sakauchi F; Washio M; Kubo T; Suzuki K; Wakai K; Nakachi K; Tajima K; Ito Y; Inaba Y; Tamakoshi A;
    Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():57-61. PubMed ID: 20553083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)-3 levels and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial (PLCO) cohort.
    Schairer C; McCarty CA; Isaacs C; Sue LY; Pollak MN; Berg CD; Ziegler RG
    Horm Cancer; 2010 Apr; 1(2):100-11. PubMed ID: 21761353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low adiponectin levels are associated with renal cell carcinoma: a case-control study.
    Spyridopoulos TN; Petridou ET; Skalkidou A; Dessypris N; Chrousos GP; Mantzoros CS;
    Int J Cancer; 2007 Apr; 120(7):1573-8. PubMed ID: 17205522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants in IGF-I, IGF-II, IGFBP-3, and adiponectin genes and colon cancer risk in African Americans and Whites.
    Keku TO; Vidal A; Oliver S; Hoyo C; Hall IJ; Omofoye O; McDoom M; Worley K; Galanko J; Sandler RS; Millikan R
    Cancer Causes Control; 2012 Jul; 23(7):1127-38. PubMed ID: 22565227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression and serum levels of insulin-like growth factors (IGFs) and IGF-binding proteins in a case of non-islet cell tumour hypoglycaemia.
    Holt RI; Teale JD; Jones JS; Quin JD; McGregor AM; Miell JP
    Growth Horm IGF Res; 1998 Dec; 8(6):447-54. PubMed ID: 10985756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of serum insulin-like growth factor-I (IGF-I) and IGF binding protein-3 to risk of prostate cancer (United States).
    Li L; Yu H; Schumacher F; Casey G; Witte JS
    Cancer Causes Control; 2003 Oct; 14(8):721-6. PubMed ID: 14674736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased serum adiponectin levels in patients with metastatic renal cell carcinoma.
    Horiguchi A; Ito K; Sumitomo M; Kimura F; Asano T; Hayakawa M
    Jpn J Clin Oncol; 2008 Feb; 38(2):106-11. PubMed ID: 18245516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor (IGF)-I, IGF-II, IGF binding protein-3, and risk of colorectal cancer: a nested case-control study in the Japan Collaborative Cohort study.
    Suzuki S; Kojima M; Tokudome S; Suzuki K; Ozasa K; Ito Y; Inaba Y; Tajima K; Nakachi K; Watanabe Y; Tamakoshi A;
    Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():45-9. PubMed ID: 20553081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF-1 and IGFBP-3: Risk of prostate cancer among men in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
    Weiss JM; Huang WY; Rinaldi S; Fears TR; Chatterjee N; Chia D; Crawford ED; Kaaks R; Hayes RB
    Int J Cancer; 2007 Nov; 121(10):2267-73. PubMed ID: 17597108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D binding protein and risk of renal cell carcinoma in the prostate, lung, colorectal and ovarian cancer screening trial.
    Kratzer TB; Weinstein SJ; Albanes D; Mondul AM
    Int J Cancer; 2020 Aug; 147(3):669-674. PubMed ID: 31659740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous hormones, inflammation, and body size in premenopausal Mexican women: results from the Mexican Teachers' Cohort (MTC, ESMaestras).
    Rinaldi S; Biessy C; de la Luz Hernandez M; Lajous M; Ortiz-Panozo E; Yunes E; Lopez-Ridaura R; Torres-Mejia G; Romieu I
    Cancer Causes Control; 2015 Mar; 26(3):475-86. PubMed ID: 25665532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.